Article Details

Zacks Investment Research Upgrades Entasis Therapeutics (ETTX) to “Buy”

Retrieved on: 2019-01-05 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Upgrades Entasis Therapeutics (ETTX) to “Buy”. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new position in shares of Entasis Therapeutics during the 3rd quarter worth approximately $12,840,000. Finally ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up